3 news items
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
LGND
3 Apr 24
. This is consistent with Ligand's strategy to reposition and maximize the value of highly differentiated and promising pharmaceutical assets by combining
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
to commercialize ZELSUVMI in partnership with a capital provider and/or strategic partner. This is consistent with Ligand's strategy to reposition and maximize
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
LGND
16 Feb 24
Operations, and Karen Reeves, M.D., to Senior Vice President of Clinical Strategy and Investments. Both executives will report to CEO Todd Davis
- Prev
- 1
- Next